申请人:Zhou Yuanxi
公开号:US20050277668A1
公开(公告)日:2005-12-15
The present invention relates to chemokine receptor binding compounds, pharmaceutical compositions and their use. More specifically, the present invention relates to modulators of chemokine receptor activity, preferably modulators of CCR5. These compounds demonstrate protective effects against infection of target cells by a human immunodeficiency virus (HIV).
本发明涉及趋化因子受体结合化合物、药物组合物及其用途。更具体地,本发明涉及趋化因子受体活性的调节剂,优选为CCR5的调节剂。这些化合物表现出对人类免疫缺陷病毒(HIV)感染靶细胞的保护效果。